The mechanistic study of Leishmania major dihydro-orotate dehydrogenase based on steady- and pre-steady-state kinetic analysis.

Leishmania major dihydro-orotate dehydrogenase (DHODHLm) has been considered as a potential therapeutic target against leishmaniasis. DHODHLm, a member of class 1A DHODH, oxidizes dihydro-orotate (DHO) to orotate (ORO) during pyrimidine biosynthesis using fumarate (FUM) as the oxidizing substrate. In the present study, the chemistry of reduction and reoxidation of the flavin mononucleotide (FMN) cofactor in DHODHLm was examined by steady- and pre-steady state kinetics under both aerobic and anaerobic environments. Our results provide for the first time the experimental evidence of co-operative behaviour in class 1A DHODH regulated by DHO binding and reveal that the initial reductive flavin half-reaction follows a mechanism with two steps. The first step is consistent with FMN reduction and shows a hyperbolic dependence on the DHO concentration with a limiting rate (kred) of 110±6 s(-1) and a K(DHO) d of 180±27 μM. Dissociation of the reduced flavin-ORO complex corresponds to the second step, with a limiting rate of 6 s(-1). In the oxidative half-reaction, the oxygen-sensitive reoxidation of the reduced FMN cofactor of DHODHLm by FUM exhibited a hyperbolic saturation profile dependent on FUM concentration allowing estimation of K(FUM) d and the limiting rate (kreox) of 258±53 μM and 35±2 s(-1), respectively. Comparison between steady- and pre-steady-state parameters together with studies of interaction for DHODHLm with both ORO and succinate (SUC), suggests that ORO release is the rate-limiting step in overall catalysis. Our results provide evidence of mechanistic differences between class 1A and class 2 individual half-reactions to be exploited for the development of selective inhibitors.

[1]  M. P. Pinheiro,et al.  Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase. , 2013, Current pharmaceutical design.

[2]  P. Vidalain,et al.  On dihydroorotate dehydrogenases and their inhibitors and uses. , 2013, Journal of medicinal chemistry.

[3]  M. P. Pinheiro,et al.  Crystal structure of dihydroorotate dehydrogenase from Leishmania major. , 2012, Biochimie.

[4]  A. Costa-Filho,et al.  Fumarate hydratase isoforms of Leishmania major: subcellular localization, structural and kinetic properties. , 2012, International journal of biological macromolecules.

[5]  J. Cano,et al.  Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.

[6]  I. Grekov,et al.  Leishmaniasis: prevention, parasite detection and treatment. , 2012, Current medicinal chemistry.

[7]  T. Aoki,et al.  Critical importance of the de novo pyrimidine biosynthesis pathway for Trypanosoma cruzi growth in the mammalian host cell cytoplasm. , 2012, Biochemical and biophysical research communications.

[8]  Susan M. Miller,et al.  Handbook of Flavoproteins: Volume 1 Oxidases, Dehydrogenases and Related Systems , 2012 .

[9]  T. Korn,et al.  Immune mechanisms of new therapeutic strategies in MS: teriflunomide. , 2012, Clinical immunology.

[10]  A. Costa-Filho,et al.  Site directed spin labeling studies of Escherichia coli dihydroorotate dehydrogenase N-terminal extension. , 2011, Biochemical and biophysical research communications.

[11]  V. Vyas,et al.  Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors. , 2011, Mini reviews in medicinal chemistry.

[12]  L. Kramer,et al.  Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis , 2011, Journal of Virology.

[13]  B. Palfey,et al.  Roles in binding and chemistry for conserved active site residues in the class 2 dihydroorotate dehydrogenase from Escherichia coli. , 2009, Biochemistry.

[14]  T. Aoki,et al.  Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction. , 2008, Biochemistry.

[15]  J. Iulek,et al.  Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain. , 2008, Biochemical and biophysical research communications.

[16]  J. Luft,et al.  Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies , 2008, Molecular microbiology.

[17]  A. Costa-Filho,et al.  Defects in vesicle core induced by escherichia coli dihydroorotate dehydrogenase. , 2008, Biophysical journal.

[18]  K. Jensen,et al.  Mechanism of flavin reduction in the class 1A dihydroorotate dehydrogenase from Lactococcus lactis. , 2007, Biochemistry.

[19]  B. Palfey,et al.  Mechanism of flavin reduction in class 2 dihydroorotate dehydrogenases. , 2006, Biochemistry.

[20]  M. Nonato,et al.  Crystallization and preliminary X-ray diffraction analysis of Leishmania major dihydroorotate dehydrogenase. , 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.

[21]  A. Costa-Filho,et al.  Cloning, expression, purification, and characterization of Leishmania major dihydroorotate dehydrogenase. , 2006, Protein expression and purification.

[22]  J. Piškur,et al.  Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans , 2006, The FEBS journal.

[23]  Ari Gafni,et al.  Single-molecule kinetics reveals signatures of half-sites reactivity in dihydroorotate dehydrogenase A catalysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Jensen,et al.  Lactococcus lactis Dihydroorotate Dehydrogenase A Mutants Reveal Important Facets of the Enzymatic Function* , 2003, Journal of Biological Chemistry.

[25]  K. Jensen,et al.  The dimeric dihydroorotate dehydrogenase A from Lactococcus lactis dissociates reversibly into inactive monomers , 2002, Protein science : a publication of the Protein Society.

[26]  W. Knecht,et al.  Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro. , 2002, Insect biochemistry and molecular biology.

[27]  K. Jensen,et al.  Dihydrooxonate is a substrate of dihydroorotate dehydrogenase (DHOD) providing evidence for involvement of cysteine and serine residues in base catalysis. , 2001, Archives of biochemistry and biophysics.

[28]  K. Jensen,et al.  Insight into the chemistry of flavin reduction and oxidation in Escherichia coli dihydroorotate dehydrogenase obtained by rapid reaction studies. , 2001, Biochemistry.

[29]  C. Pickart,et al.  Dihydroorotate dehydrogenase from Clostridium oroticum is a class 1B enzyme and utilizes a concerted mechanism of catalysis. , 2000, Biochemistry.

[30]  R. Lill,et al.  Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase. , 2000, European journal of biochemistry.

[31]  J. Clardy,et al.  Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. , 2000, Structure.

[32]  J. Marcinkeviciene,et al.  Dihydroorotate dehydrogenase B of Enterococcus faecalis. Characterization and insights into chemical mechanism. , 1999, Biochemistry.

[33]  D. Batt Inhibitors of dihydroorotate dehydrogenase , 1999 .

[34]  Sine Larsen,et al.  The crystal structure of lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function , 1998, Protein science : a publication of the Protein Society.

[35]  K. Jensen,et al.  Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. , 1997, Biochemistry.

[36]  V. Hines,et al.  Mechanistic studies on the bovine liver mitochondrial dihydroorotate dehydrogenase using kinetic deuterium isotope effects. , 1989, Biochemistry.

[37]  W. Cleland,et al.  The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations. 1963. , 1989, Biochimica et biophysica acta.